Skip to content

CRISPR/Cas12a-powered self-sustaining catalytic nucleic acid circuit for highly sensitive detection of aflatoxin B1.

Oct 2026 · Talanta: The International Journal of Pure and Applied Analytical Chemistry · Vol 313 Pt B, pp. 130809 · 0 citations · 26 references
Medicine

Abstract

Aflatoxin B1 (AFB1) is a highly toxic mycotoxin and strongly carcinogenic and teratogenic to humans. Achieving CRISPR-based sensing system for highly sensitive detection of AFB1 remains a significant challenge. A CRISPR/Cas12a-powered self-sustaining catalytic nucleic acid circuit (CPSCN) is proposed for the sensitive and accurate detection of aflatoxin B1 (AFB1). In the CPSCN sensing system, CRISPR/Cas12a/gRNA1 indirectly recognizes AFB1 by aptamer and effectively triggers trans-cleavage of a pair of self-reporting single-stranded DNA-locked RNA2 fluorescence probes (named as dual-winged fluorescence probe). The released RNA2 then initiates an autocatalytic positive feedback loop, resulting in continuous probe cleavage. The CPSCN system achieves highly sensitive detection in a single-enzyme one-step process. The method exhibits excellent quantitative capability for AFB1 detection with a detection limit of 7.5 pg/mL. In real samples, the detection results of the proposed biosensor show high consistency with those obtained by enzyme-linked immunosorbent assay (ELISA). This work not only provides a novel strategy for AFB1 detection with high sensitivity, robustness, and operational simplicity, but also offers a new insight for designing signal amplification strategies of CRISPR-based biosensors.

View source

Similar papers

Open access Dec 2026

CRISPR/Cas12a-based simplified lateral flow assay for sensitive detection of OTA and AFB1.

Mycotoxin contamination in agricultural commodities poses serious health risks, necessitating sensitive and user-friendly detection methods for food safety monitoring. Here, we present a multiplex CRISPR/Cas12a-assisted lateral flow assay (MC-LFA) for the parallel detection of Ochratoxin A (OTA) and Aflatoxin B1 (AFB1)...

Wen-Jun Jiang, Yi-Dan Zhu, Jing X. Kang et al. · 0 citations
Oct 2026

A programmable aptamer-triggered B-PER/CRISPR cascade amplification platform for ultrasensitive detection of Staphylococcus aureus.

Rapid and sensitive detection of Staphylococcus aureus (S. aureus) is critical for food safety and public health. Herein, this work developed an ABC (aptamer-B-PER-CRISPR) cascade detection platform, where B-PER stands for bidirectional primer exchange reaction, that integrates aptamer-mediated target recognition, B-PE...

Jia-Lin Jiang, Yuan Peng, Wen-Jie Ma et al. · 0 citations
Oct 2026

A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus.

CRISPR-Cas12a biosensing is hindered by insufficient sensitivity that necessitates pre-amplification, as well as the limited ability to directly detect non-nucleic-acid targets. Herein, we developed a CRISPR-Cas12a biosensor centered on a DNAzyme-activated engineered crRNA (e-crRNA), enabling Mn2+-responsive control ov...

Xin-Rui Wang, Xue-Ning Shi, Xiao-Xi Zheng et al. · 0 citations
#gene editing Open access Oct 2026

CRISPR/Cas12a-Based Aptasensor for Cas9 Protein Detection in Spiked Food Matrices

Residual gene editors are a concern associated with the widespread application of CRISPR/Cas9 technology. Here, we developed a CRISPR/Cas12a-based fluorescent aptasensor for the qualitative and quantitative detection of Cas9 protein. Secondary structure prediction and molecular docking were combined to identify potenti...

Zi-Zhao Wang, Jing Wang, Ling Li et al. · 0 citations
Oct 2026

Single-Atom Nanozyme Integrated Double-Clasp Transition Probe-Driven CRISPR/Cas12a Cascade for Preamplification-Free Detection of Non-Nucleic Acid Targets.

CRISPR/Cas12a diagnostics have greatly advanced nucleic acid testing, yet their extension to non-nucleic acid targets remains constrained by the intricate preamplification process and by inefficient signal transduction. Herein, we present a non-nucleic acid detection platform that integrates a CRISPR/Cas12a positive-fe...

Jian-Le Wang, Qiu-Yun Tian, Yu-Ling Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.